Sector: Health Care
Director information for ABBVIE INC (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Brett J. Hart | President, United Airlines Holdings, Inc. | 57 | ["President of United Airlines Holdings, Inc.", "Executive Vice President and Chief Administrative Officer", "General Counsel", "acting Chief Executive Officer of UAL and United Airlines, Inc.", "Senior Vice President, General Counsel and Secretary of UAL, United and Continental", "Executive Vice President, General Counsel and Corporate Secretary at Sara Lee Corporation"] | ["Compensation", "Nominations & Governance"] | 2026 |
| Edward J. Rapp | Director | 68 | ["Retired Group President for Resource Industries of Caterpillar Inc.", "Group President at Caterpillar Inc. from 2014 to 2016", "CFO at Caterpillar Inc. from 2010 to 2013", "Extensive global experience", "Experience in climate change and emissions oversight"] | ["Audit", "Nominations & Governance"] | 2026 |
| E. Rapp | ["audit committee financial expert"] | ["audit committee"] | 2026 | ||
| Frederick H. Waddell | Director | 72 | ["Former Chairman of the Board and Chief Executive Officer of Northern Trust Corporation and The Northern Trust Company", "Experience overseeing a company's strategic priorities during changing economic conditions", "Director of International Business Machines Corporation"] | ["Audit (Chair)", "Compensation"] | 2026 |
| F. Waddell | Chair | ["audit committee financial expert"] | ["audit committee"] | 2026 | |
| Jennifer L. Davis | Chief Executive Officer, Health Care | 54 | ["30+ year career at Procter & Gamble", "President, Feminine Care (2019 - 2022)", "President, Global Feminine Care (2018 - 2019)", "Vice President - Feminine Care, North America and Brand Franchise Leader, Tampax (2016 - 2018)", "Experience in marketing and commercial strategy", "Corporate strategy and leadership", "Consumer behavior and business development expertise", "Oversight of health care research and development, manufacturing, quality, and supply, and regulatory compliance"] | ["Nominations & Governance"] | 2026 |
| Melody B. Meyer | Director | 68 | ["Retired President, Chevron Asia Pacific Exploration and Production", "Served as President of Chevron Asia Pacific Exploration and Production Company from March 2011 to April 2016", "Served as President of Chevron Energy Technology Company from 2008 to 2011", "Held various leadership roles in global and U.S. locations during her thirty-seven year career at Chevron", "President of Melody Meyer Energy, LLC, a private consulting firm, since June 2016", "Director at bp p.l.c., term ends in April 2026", "Previously served as a director of NOV, Inc. from 2017 to 2023", "Acquired operational, management, strategic planning, and financial expertise", "Provides strong human capital management oversight experience"] | ["Audit and Public Policy & Sustainability (Chair)"] | 2026 |
| M. Meyer | Chair | [] | ["public policy and sustainability committee"] | 2026 | |
| R. Alpern | [] | ["public policy and sustainability committee"] | 2026 | ||
| R. Austin | ["audit committee financial expert"] | ["audit committee", "public policy and sustainability committee"] | 2026 | ||
| Rebecca B. Roberts | Retired President of Chevron Pipe Line Company | 73 | ["Served as President of Chevron Pipe Line Company from 2006 to 2011", "President of Chevron Global Power Generation from 2003 to 2006", "Various technical and management positions during a thirty-six year career with Chevron", "Background as a chemist and research scientist", "Served as a director of Enbridge, Inc. from 2015 to 2018", "Director of Black Hills Corporation from 2011 to 2025", "Director of MSA Safety Incorporated from 2013 to 2025", "Expertise in management, business development, operational, environmental and safety, marketing, and strategy development", "Broad experience across Asia, Europe, and Central America"] | ["Nominations & Governance", "Public Policy & Sustainability"] | 2026 |
| Robert A. Michael | Chairman of the Board and Chief Executive Officer | 55 | ["Chairman and Chief Executive Officer of AbbVie Inc.", "Chief Executive Officer starting in 2024", "President and Chief Operating Officer from July 2023 to June 2024", "Vice Chairman and President from June 2022 to July 2023", "Vice Chairman, Finance and Commercial Operations and Chief Financial Officer from June 2021 to June 2022", "Executive Vice President, Chief Financial Officer from 2019 to 2021", "Senior Vice President, Chief Financial Officer from 2018 to 2019", "Joined Abbott in 1993"] | ["Audit", "Compensation"] | 2026 |
| Roxanne S. Austin | Director | 65 | ["President of Austin Investment Advisors", "Chair of the U.S. Mid-market Investment Advisory Committee of EQT Partners", "Former President and CEO of Move Networks, Inc.", "Former President and COO of DIRECTV, Inc.", "Former Executive VP and CFO of Hughes Electronics Corporation", "Former partner of Deloitte & Touche LLP", "Director of Crowdstrike, Inc.", "Director of Freshworks, Inc.", "Director of Verizon Communications Inc.", "Former director of Abbott Laboratories", "Former director of Teledyne Technologies, Inc.", "Former director of Target Corporation", "Former director of Telefonaktiebolaget LM Ericsson"] | ["Audit", "Compensation", "Nominations & Governance", "Public Policy & Sustainability"] | 2026 |
| R. Roberts | [] | ["public policy and sustainability committee"] | 2026 | ||
| S. Quaggin | [] | ["public policy and sustainability committee"] | 2026 | ||
| Susan E. Quaggin, M.D. | Director | 62 | ["Irving S. Cutter Professor and Chair of Medicine, Northwestern University Feinberg School of Medicine", "Director of the Feinberg Cardiovascular and Renal Research Institute since 2013", "Council member of the Association of American Physicians", "Former President of the American Society of Nephrology in 2021 and 2022"] | ["Public Policy & Sustainability"] | 2026 |
| T. Falk | ["audit committee financial expert"] | ["audit committee"] | 2026 | ||
| Thomas C. Freyman | Director | 71 | ["Retired Executive Vice President, Finance and Administration at Abbott Laboratories", "Director at Allergan from 2018 to 2020", "Executive Vice President, Finance and Administration at Abbott Laboratories from 2015 to 2017", "Chief Financial Officer and Executive Vice President at Abbott", "Director of Tenneco Inc. from 2013 to 2022", "Director of Hanger, Inc. from 2017 to 2022", "Extensive experience in health care and finance", "Expertise in complex accounting and financial issues", "Manufacturing and environmental, health, and safety oversight experience"] | ["Compensation", "Nominations & Governance"] | 2026 |
| Thomas J. Falk | Director | 67 | ["Retired Chairman and Chief Executive Officer, Kimberly-Clark Corporation", "Served 36 years at Kimberly-Clark Corporation", "Management experience overseeing a complex multinational business", "Strategic, management, financial, and operational expertise", "Lead Independent Director at Lockheed Martin"] | ["Audit"] | 2026 |
| W. Burnside | [] | ["public policy and sustainability committee"] | 2026 | ||
| William H.L. Burnside | Director | 74 | ["Retired Senior Vice President and Director at The Boston Consulting Group", "Experience in corporate finance and capital markets", "Global and domestic strategic advisory experience", "Financial forecasting and planning expertise", "Mergers and acquisitions experience", "Human capital management knowledge", "Marketing and risk planning skills"] | ["Audit", "Public Policy & Sustainability"] | 2026 |
